Evidence map›Paper›PMID 28140573›Full record

ArticleJournal of the American Chemical Society2017

Strain-Release Heteroatom Functionalization: Development, Scope, and Stereospecificity.

Justin M Lopchuk, Kasper Fjelbye, Yu Kawamata, Lara R Malins, Chung-Mao Pan, Ryan Gianatassio, Jie Wang, Liher Prieto, James Bradow, Thomas A Brandt and 14 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 332 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Stereocontrolled Synthesis of Polysubstituted Housanes viaJournal of the American Chemical Society · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Boron-Enabled Stereoselective Synthesis of Polysubstituted Housanes.Journal of the American Chemical Society · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 3 institutions in 1 country.

Justin M LopchukDepartment of Chemistry, The Scripps Research Institute , 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
Kasper FjelbyeDepartment of Chemistry, The Scripps Research Institute , 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
Yu KawamataDepartment of Chemistry, The Scripps Research Institute , 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
Lara R MalinsDepartment of Chemistry, The Scripps Research Institute , 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
Chung-Mao PanDepartment of Chemistry, The Scripps Research Institute , 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
Ryan GianatassioDepartment of Chemistry, The Scripps Research Institute , 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
Jie WangDepartment of Chemistry, The Scripps Research Institute , 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
Liher PrietoDepartment of Chemistry, The Scripps Research Institute , 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
James BradowPfizer Worldwide Research and Development , Eastern Point Road, Groton, Connecticut 06340, United States.
Thomas A BrandtPfizer Worldwide Research and Development , Eastern Point Road, Groton, Connecticut 06340, United States.
Michael R CollinsDepartment of Chemistry, La Jolla Laboratories, Pfizer Inc. , 10770 Science Center Drive, San Diego, California 92121, United States.
Jeff ElleraasDepartment of Chemistry, La Jolla Laboratories, Pfizer Inc. , 10770 Science Center Drive, San Diego, California 92121, United States.
Jason EwanickiDepartment of Chemistry, La Jolla Laboratories, Pfizer Inc. , 10770 Science Center Drive, San Diego, California 92121, United States.
William FarrellDepartment of Chemistry, La Jolla Laboratories, Pfizer Inc. , 10770 Science Center Drive, San Diego, California 92121, United States.
Olugbeminiyi O FadeyiPfizer Worldwide Research and Development , Eastern Point Road, Groton, Connecticut 06340, United States.
Gary M GallegoDepartment of Chemistry, La Jolla Laboratories, Pfizer Inc. , 10770 Science Center Drive, San Diego, California 92121, United States.
James J MousseauPfizer Worldwide Research and Development , Eastern Point Road, Groton, Connecticut 06340, United States.
Robert OliverPfizer Worldwide Research and Development , Eastern Point Road, Groton, Connecticut 06340, United States.
Neal W SachDepartment of Chemistry, La Jolla Laboratories, Pfizer Inc. , 10770 Science Center Drive, San Diego, California 92121, United States.
Jason K SmithPfizer Worldwide Research and Development , Eastern Point Road, Groton, Connecticut 06340, United States.
Jillian E SpanglerDepartment of Chemistry, La Jolla Laboratories, Pfizer Inc. , 10770 Science Center Drive, San Diego, California 92121, United States.
Huichin ZhuDepartment of Chemistry, La Jolla Laboratories, Pfizer Inc. , 10770 Science Center Drive, San Diego, California 92121, United States.
Jinjiang ZhuDepartment of Chemistry, La Jolla Laboratories, Pfizer Inc. , 10770 Science Center Drive, San Diego, California 92121, United States.
Phil S BaranDepartment of Chemistry, The Scripps Research Institute , 10550 North Torrey Pines Road, La Jolla, California 92037, United States.ORCID 0000-0001-9193-9053
Fleet Science Center · USScripps Research Institute · USPfizer (United States) · US

Funding

Scalable Synthesis and New Bond DisconnectionsR35GM118176 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI BARAN, PHIL S · 2016 to 2025
$11.5M
Synthesis of diterpenoid alkaloids by site-selective C-H functionalizationF32GM113385 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI LOPCHUK, JUSTIN MATTHEW · 2015 to 2016
$106k
NIGMS NIH HHS F32 GM113385NIGMS NIH HHS R35 GM118176
6 · The paper itself

Abstract

Driven by the ever-increasing pace of drug discovery and the need to push the boundaries of unexplored chemical space, medicinal chemists are routinely turning to unusual strained bioisosteres such as bicyclo[1.1.1]pentane, azetidine, and cyclobutane to modify their lead compounds. Too often, however, the difficulty of installing these fragments surpasses the challenges posed even by the construction of the parent drug scaffold. This full account describes the development and application of a general strategy where spring-loaded, strained C-C and C-N bonds react with amines to allow for the "any-stage" installation of small, strained ring systems. In addition to the functionalization of small building blocks and late-stage intermediates, the methodology has been applied to bioconjugation and peptide labeling. For the first time, the stereospecific strain-release "cyclopentylation" of amines, alcohols, thiols, carboxylic acids, and other heteroatoms is introduced. This report describes the development, synthesis, scope of reaction, bioconjugation, and synthetic comparisons of four new chiral "cyclopentylation" reagents.

Indexed as

AlcoholsAminesCarboxylic AcidsMolecular StructureStereoisomerismSulfhydryl CompoundsAlcoholsAminesCarboxylic AcidsSulfhydryl Compounds

Identifiers

PMID28140573
PMCPMC5334783
OpenAlexW2585403732

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.